Bariatric surgery can lower the efficacy of DOACs

3Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

A 39-year-old woman who was taking the contraceptive pill was admitted with right leg deep venous thrombosis (DVT). She was started on apixaban tablets, but after 8 days developed proximal progression of the DVT and pulmonary embolism. Her medical history later showed a history of sleeve gastrectomy. The patient responded to a vitamin K antagonist after heparin. The failure of the antithrombotic drug shed light on the efficacy and changed pharmacodynamics of direct oral anticoagulants (DOACs) after bariatric surgery in the absence of commercially available blood monitoring tests. LEARNING POINTS • Bariatric surgery causes complicated changes in the pharmacodynamics of direct oral anticoagulants (DOACs). • The absence of clinical data on the efficacy of DOACs after various bariatric procedures makes it difficult to justify their use after bariatric surgery.

Cite

CITATION STYLE

APA

Bitar, Z. I., Maadarani, O. S., Mohsen, M. J., & Alkazemi, N. U. (2020). Bariatric surgery can lower the efficacy of DOACs. European Journal of Case Reports in Internal Medicine, 7(12). https://doi.org/10.12890/2020_001954

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free